Imagine creating a groundbreaking medical treatment and getting it approved by the FDA, only to have unwieldy technology prevent you from sharing it online with those who could really benefit from it. For far too long, this has been Biogen’s reality.
The biotechnology company researches and manufactures medicines to treat spinal muscular atrophy, Alzheimer's, and MS. Their digital platforms educate physicians and patients on their offerings and clinical trials — until recently, publishing this content was a long, drawn-out process, thanks to a well-known but rigid content management system (CMS). The platform lacked key features to facilitate translations, and building new webpages was both time-consuming and costly. There was also the matter of content sprawl. Biogen’s marketing team was spread across the globe, each tasked with creating their own content. This led to disjointed web pages and inconsistent branding.
Eager to speed up time to market and unify content, Biogen began actively looking for a flexible, headless alternative to its legacy technology. This type of technology decouples the content layer from the presentation layer, allowing teams to manage content for different locales from a single space.
“Our goal was to simplify the way web pages are built, streamline localization, and reduce the overall cost of building pages. We also wanted to find a way to have content creators publish pages in near real-time, and not have to wait for a deployment to production or deployment from lower environments to higher environments,” shared Arthur Allard, Customer Solutions Lead at Biogen.
In 2020, Biogen switched to Contentful — and got exactly what they were looking for.